We seek out the unique, the talented, the diverse and the brave. People for whom passion is a way of life.

Design, quality and integrity is inseparable from our culture. Fridcorp has an impressive leadership and delivery team that is involved in every aspect of every project that carries the Fridcorp name.

The Directors

Paul Fridman

Founder, Director

Paul established Fridcorp in 1997 and has a genuine personal commitment to quality design. An entrepreneurial property developer, he started the company to seize an opportunity in the market for attainable luxury.

Paul's expertise includes site identification, negotiation with key stakeholders and, most importantly, creating distinction in architecture and design. His passion for design is evident in every Fridcorp development.

Paul looks for this passion, talent and innovation in the people he works with and collaborates with his team, creating an enironment where individuals collectively strive to achieve excellence.

Nigel Givoni

CEO, Director

With an established background in general management, finance and marketing in both national and international operations, Nigel joined Fridcorp as CEO in 2001 to maximise the business' growth potential.


Nigel's extensive product development, feasibility analysis and negotiation skills are integral to the operational efficiencies of the business. Through the economic cycles of the property market, Nigel's perceptive focus on corporate, legal and finance structures has ensured the long term security, diversification and expansion of the Fridcorp Group.

Leadership Team

Chris Roche

Development Director

Chris Roche has worked in the development industry for over 15 years, initiating and managing a portfolio of large and mid-scale residential and mixed-use projects both in Australia and the UK. At Fridcorp since 2007, Chris' achievements include the acquisition and delivery of Fridcorp's prestigious elm, lilli and Avenue projects. Chris is currently responsible for planning, design and delivery of the company's recent development site acquisition in Sydney.